_id

69105235ccc777a4e85d54ad

Ticker

CNTA

Name

Centessa Pharmaceuticals PLC ADR

Exchange

NASDAQ

Address

1 Ashley Road, Altrincham, United Kingdom, WA14 2DT

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://centessa.com

Description

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Last Close

27.18

Volume

1217153

Current Price

26.51

Change

-2.4650478292862332

Last Updated

2025-11-29T11:41:57.940Z

Image

data:image/webp;base64,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

Ipo Date

2021-05-28T00:00:00.000Z

Market Cap

4240579072

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8974615384615383

Sentiment Sources

13

Rating

4.6364

Target Price

36.3846

Strong Buy

7

Buy

4

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

53790000

Operating Income

-53790000

Interest Expense

2890000

Pretax Income

-54725000

Net Income

-54891000

Eps

-0.40913514684009566

Dividends Per Share

-

Shares Outstanding

146075743

Income Tax Expense

166000

EBITDA

-51598000

Operating Margin

-

Total Other Income Expense Net

-935000

Cash

50811000

Short Term Investments

195403000

Receivables

52213000

Inventories

-

Total Current Assets

307675000

Property Plant Equipment

11189000

Total Assets

448300000

Payables

8683000

Short Term Debt

684000

Long Term Debt

109816000

Total Liabilities

146726000

Equity

301574000

Depreciation

237000

Change In Working Capital

-11264000

Cash From Operations

-58312000

Capital Expenditures

234000

Cash From Investing

61945000

Cash From Financing

3437000

Net Change In Cash

6569000

PE

-

PB

11.793702948264771

ROE

-18.201502782070072

ROA

-12.244256078518848

FCF

-58546000

Fcf Percent

-

Piotroski FScore

0

Health Score

34

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

1

Quality Investing Score

3

Value Investing Score

3.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

53790000

Quarters > 0 > income Statement > operating Income

-53790000

Quarters > 0 > income Statement > interest Expense

2890000

Quarters > 0 > income Statement > pretax Income

-54725000

Quarters > 0 > income Statement > net Income

-54891000

Quarters > 0 > income Statement > eps

-0.40913514684009566

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

134163492

Quarters > 0 > income Statement > income Tax Expense

166000

Quarters > 0 > income Statement > EBITDA

-51598000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-935000

Quarters > 0 > balance Sheet > cash

50811000

Quarters > 0 > balance Sheet > short Term Investments

195403000

Quarters > 0 > balance Sheet > receivables

52213000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

307675000

Quarters > 0 > balance Sheet > property Plant Equipment

11189000

Quarters > 0 > balance Sheet > total Assets

448300000

Quarters > 0 > balance Sheet > payables

8683000

Quarters > 0 > balance Sheet > short Term Debt

684000

Quarters > 0 > balance Sheet > long Term Debt

109816000

Quarters > 0 > balance Sheet > total Liabilities

146726000

Quarters > 0 > balance Sheet > equity

301574000

Quarters > 0 > cash Flow > net Income

-54891000

Quarters > 0 > cash Flow > depreciation

237000

Quarters > 0 > cash Flow > change In Working Capital

-11264000

Quarters > 0 > cash Flow > cash From Operations

-58312000

Quarters > 0 > cash Flow > capital Expenditures

234000

Quarters > 0 > cash Flow > cash From Investing

61945000

Quarters > 0 > cash Flow > cash From Financing

3437000

Quarters > 0 > cash Flow > net Change In Cash

6569000

Quarters > 0 > ratios > PE

-0.40913514684009566

Quarters > 0 > ratios > PB

11.793702948264771

Quarters > 0 > ratios > ROE

-18.201502782070072

Quarters > 0 > ratios > ROA

-12.244256078518848

Quarters > 0 > ratios > FCF

-58546000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

34

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

228674

Quarters > 1 > income Statement > gross Profit

-228674

Quarters > 1 > income Statement > operating Expenses

54653000

Quarters > 1 > income Statement > operating Income

-54653000

Quarters > 1 > income Statement > interest Expense

2884000

Quarters > 1 > income Statement > pretax Income

-49565000

Quarters > 1 > income Statement > net Income

-50343000

Quarters > 1 > income Statement > eps

-0.37660066785407753

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

133677405

Quarters > 1 > income Statement > income Tax Expense

778000

Quarters > 1 > income Statement > EBITDA

-46455000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

5088000

Quarters > 1 > balance Sheet > cash

44242000

Quarters > 1 > balance Sheet > short Term Investments

206482000

Quarters > 1 > balance Sheet > receivables

44096000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

300363000

Quarters > 1 > balance Sheet > property Plant Equipment

11272000

Quarters > 1 > balance Sheet > total Assets

492127000

Quarters > 1 > balance Sheet > payables

5692000

Quarters > 1 > balance Sheet > short Term Debt

656000

Quarters > 1 > balance Sheet > long Term Debt

109545000

Quarters > 1 > balance Sheet > total Liabilities

147208000

Quarters > 1 > balance Sheet > equity

344919000

Quarters > 1 > cash Flow > net Income

-50343000

Quarters > 1 > cash Flow > depreciation

226000

Quarters > 1 > cash Flow > change In Working Capital

18553000

Quarters > 1 > cash Flow > cash From Operations

-22452000

Quarters > 1 > cash Flow > capital Expenditures

126000

Quarters > 1 > cash Flow > cash From Investing

-39954000

Quarters > 1 > cash Flow > cash From Financing

1605000

Quarters > 1 > cash Flow > net Change In Cash

-60914000

Quarters > 1 > ratios > PE

-0.37660066785407753

Quarters > 1 > ratios > PB

10.2742615122681

Quarters > 1 > ratios > ROE

-14.595600706252773

Quarters > 1 > ratios > ROA

-10.229676485947733

Quarters > 1 > ratios > FCF

-22578000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

15000000

Quarters > 2 > income Statement > cost Of Revenue

217833

Quarters > 2 > income Statement > gross Profit

15000000

Quarters > 2 > income Statement > operating Expenses

45777000

Quarters > 2 > income Statement > operating Income

-30777000

Quarters > 2 > income Statement > interest Expense

2877000

Quarters > 2 > income Statement > pretax Income

-24738000

Quarters > 2 > income Statement > net Income

-26135000

Quarters > 2 > income Statement > eps

-0.19645353819324382

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

133034000

Quarters > 2 > income Statement > income Tax Expense

1397000

Quarters > 2 > income Statement > EBITDA

-21644000

Quarters > 2 > income Statement > operating Margin

-205.18

Quarters > 2 > income Statement > total Other Income Expense Net

6039000

Quarters > 2 > balance Sheet > cash

105156000

Quarters > 2 > balance Sheet > short Term Investments

179349000

Quarters > 2 > balance Sheet > receivables

52704000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

347718000

Quarters > 2 > balance Sheet > property Plant Equipment

11459000

Quarters > 2 > balance Sheet > total Assets

527845000

Quarters > 2 > balance Sheet > payables

5132000

Quarters > 2 > balance Sheet > short Term Debt

629000

Quarters > 2 > balance Sheet > long Term Debt

109252000

Quarters > 2 > balance Sheet > total Liabilities

141598000

Quarters > 2 > balance Sheet > equity

386247000

Quarters > 2 > cash Flow > net Income

-26135000

Quarters > 2 > cash Flow > depreciation

217000

Quarters > 2 > cash Flow > change In Working Capital

-38539000

Quarters > 2 > cash Flow > cash From Operations

-57246000

Quarters > 2 > cash Flow > capital Expenditures

3.53

Quarters > 2 > cash Flow > cash From Investing

-222388000

Quarters > 2 > cash Flow > cash From Financing

3086000

Quarters > 2 > cash Flow > net Change In Cash

-278065000

Quarters > 2 > ratios > PE

-0.19645353819324382

Quarters > 2 > ratios > PB

9.130766944468178

Quarters > 2 > ratios > ROE

-6.766395596600103

Quarters > 2 > ratios > ROA

-4.9512641021512

Quarters > 2 > ratios > FCF

-57246003.53

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-3.8164002353333335

Quarters > 2 > health Score

26

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

952252

Quarters > 3 > income Statement > cost Of Revenue

476126

Quarters > 3 > income Statement > gross Profit

476126

Quarters > 3 > income Statement > operating Expenses

74580000

Quarters > 3 > income Statement > operating Income

-74580000

Quarters > 3 > income Statement > interest Expense

2479000

Quarters > 3 > income Statement > pretax Income

-110279000

Quarters > 3 > income Statement > net Income

-111329000

Quarters > 3 > income Statement > eps

-0.8430821658462704

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

132050000

Quarters > 3 > income Statement > income Tax Expense

1050000

Quarters > 3 > income Statement > EBITDA

-107570000

Quarters > 3 > income Statement > operating Margin

-7831.960447444584

Quarters > 3 > income Statement > total Other Income Expense Net

-35699000

Quarters > 3 > balance Sheet > cash

383221000

Quarters > 3 > balance Sheet > short Term Investments

98956000

Quarters > 3 > balance Sheet > receivables

45296000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

536409000

Quarters > 3 > balance Sheet > property Plant Equipment

11757000

Quarters > 3 > balance Sheet > total Assets

576798000

Quarters > 3 > balance Sheet > payables

7143000

Quarters > 3 > balance Sheet > short Term Debt

577000

Quarters > 3 > balance Sheet > long Term Debt

108940000

Quarters > 3 > balance Sheet > total Liabilities

175253000

Quarters > 3 > balance Sheet > equity

401545000

Quarters > 3 > cash Flow > net Income

-111329000

Quarters > 3 > cash Flow > depreciation

227867

Quarters > 3 > cash Flow > change In Working Capital

25198865

Quarters > 3 > cash Flow > cash From Operations

-42800000

Quarters > 3 > cash Flow > capital Expenditures

1.08

Quarters > 3 > cash Flow > cash From Investing

25000000

Quarters > 3 > cash Flow > cash From Financing

2963000

Quarters > 3 > cash Flow > net Change In Cash

-11805000

Quarters > 3 > ratios > PE

-0.8430821658462704

Quarters > 3 > ratios > PB

8.717940704030681

Quarters > 3 > ratios > ROE

-27.725161563461132

Quarters > 3 > ratios > ROA

-19.30121116924816

Quarters > 3 > ratios > FCF

-42800001.08

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-44.94608683415734

Quarters > 3 > health Score

27

Valuation > metrics > PE

-0.40913514684009566

Valuation > metrics > PB

11.793702948264771

Valuation > final Score

20

Valuation > verdict

293.1% Overvalued

Profitability > metrics > ROE

-18.201502782070072

Profitability > metrics > ROA

-17.840578532542455

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.48653398502523426

Risk > metrics > Interest Coverage

-18.612456747404845

Risk > final Score

-14

Risk > verdict

High

Liquidity > metrics > Current Ratio

32.84669584712288

Liquidity > metrics > Quick Ratio

32.84669584712288

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

15

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-16

Prev Risks > 1

17

Prev Risks > 2

-60

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:21:16.887Z